These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22902252)

  • 1. [RECIST and the radiologist].
    Cervera Deval J
    Radiologia; 2014; 56(3):193-205. PubMed ID: 22902252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of WHO, RECIST 1.1, EORTC, and PERCIST criteria in the evaluation of treatment response in malignant solid tumors.
    Aras M; Erdil TY; Dane F; Gungor S; Ones T; Dede F; Inanir S; Turoglu HT
    Nucl Med Commun; 2016 Jan; 37(1):9-15. PubMed ID: 26440568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revised RECIST guideline version 1.1: What oncologists want to know and what radiologists need to know.
    Nishino M; Jagannathan JP; Ramaiya NH; Van den Abbeele AD
    AJR Am J Roentgenol; 2010 Aug; 195(2):281-9. PubMed ID: 20651182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pitfalls in RECIST Data Extraction for Clinical Trials: Beyond the Basics.
    Abramson RG; McGhee CR; Lakomkin N; Arteaga CL
    Acad Radiol; 2015 Jun; 22(6):779-86. PubMed ID: 25794800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the RECIST and PERCIST criteria in solid tumors: a pooled analysis and review.
    Min SJ; Jang HJ; Kim JH
    Oncotarget; 2016 May; 7(19):27848-54. PubMed ID: 27036043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging criteria for assessing tumour response: RECIST, mRECIST, Cheson.
    Fournier L; Ammari S; Thiam R; Cuénod CA
    Diagn Interv Imaging; 2014; 95(7-8):689-703. PubMed ID: 24951349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response criteria in oncologic imaging: review of traditional and new criteria.
    Tirkes T; Hollar MA; Tann M; Kohli MD; Akisik F; Sandrasegaran K
    Radiographics; 2013; 33(5):1323-41. PubMed ID: 24025927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Response criteria for malignant melanoma: RECIST and irRC].
    Spiro J; Maintz D; Persigehl T
    Radiologe; 2015 Feb; 55(2):127-35. PubMed ID: 25637198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiologic assessment of response to therapy: comparison of RECIST Versions 1.1 and 1.0.
    Chalian H; Töre HG; Horowitz JM; Salem R; Miller FH; Yaghmai V
    Radiographics; 2011; 31(7):2093-105. PubMed ID: 22084190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pearls and pitfalls of response evaluation criteria in solid tumors (RECIST) v1.1 non-target lesion assessment.
    Morse B; Jeong D; Ihnat G; Silva AC
    Abdom Radiol (NY); 2019 Feb; 44(2):766-774. PubMed ID: 30196362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RECIST - learning from the past to build the future.
    Litière S; Collette S; de Vries EG; Seymour L; Bogaerts J
    Nat Rev Clin Oncol; 2017 Mar; 14(3):187-192. PubMed ID: 27995946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiological monitoring of the treatment of solid tumors in practice.
    Ganten MK; Ganten TM; Schlemmer HP
    Rofo; 2014 May; 186(5):466-73. PubMed ID: 24563412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.
    Lastoria S; Piccirillo MC; Caracò C; Nasti G; Aloj L; Arrichiello C; de Lutio di Castelguidone E; Tatangelo F; Ottaiano A; Iaffaioli RV; Izzo F; Romano G; Giordano P; Signoriello S; Gallo C; Perrone F
    J Nucl Med; 2013 Dec; 54(12):2062-9. PubMed ID: 24136935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of volumetric measurement processes in oncology imaging trials for screening and evaluation of tumors as per response evaluation criteria in solid tumors.
    Vemuri RC; Jarecha R; Hwi KK; Gundamaraju R; Maruthikanth A; Kulkarni A; Reddy S
    Asian Pac J Cancer Prev; 2014; 15(5):2375-8. PubMed ID: 24716987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of RECIST 1.1 and iRECIST for Response Evaluation in Solid Tumours].
    Houdek Š; Büchler T; Kindlová E
    Klin Onkol; 2017; 30(Supplementum3):32-39. PubMed ID: 29239190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations with the response evaluation criteria in solid tumors (RECIST) guidance in disseminated pediatric malignancy.
    Barnacle AM; McHugh K
    Pediatr Blood Cancer; 2006 Feb; 46(2):127-34. PubMed ID: 16231313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative imaging in oncology patients: Part 2, oncologists' opinions and expectations at major U.S. cancer centers.
    Jaffe TA; Wickersham NW; Sullivan DC
    AJR Am J Roentgenol; 2010 Jul; 195(1):W19-30. PubMed ID: 20566776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving accuracy in reporting CT scans of oncology patients: assessing the effect of education and feedback interventions on the application of the Response Evaluation Criteria in Solid Tumors (RECIST) criteria.
    Andoh H; McNulty NJ; Lewis PJ
    Acad Radiol; 2013 Mar; 20(3):351-7. PubMed ID: 23452481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of response criteria for clinical trials of sarcoma treatment.
    Schuetze SM; Baker LH; Benjamin RS; Canetta R
    Oncologist; 2008; 13 Suppl 2():32-40. PubMed ID: 18434637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives.
    Marcus CD; Ladam-Marcus V; Cucu C; Bouché O; Lucas L; Hoeffel C
    Crit Rev Oncol Hematol; 2009 Dec; 72(3):217-38. PubMed ID: 18760935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.